Vistagen Leadership Friday, July 31, 2026 0.00 Neutral

Vistagen Therapeutics enters indemnification agreement with its director

Vistagen Therapeutics, Inc. executed an indemnification agreement with Director Douglas J. Williamson, bolstering protections against executive liability.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day